Sujal Shah, CEO: CymaBay Therapeutics CBAY Sell · Filed 23/10/10

Trade details

Type: Insider sale
Amount: $921,026.2
Shares · price: 64,861 sh · $14.20 a share
Held after: 171,301 sh
Stock: CymaBay Therapeutics CBAY
Person: Sujal ShahCEO
Trade date: 23/10/09
Filed: 23/10/10
Days to filing: 1 days

Sold 27.5% of holdings

Share of holding sold: 27.5%

CymaBay Therapeutics trades, last 26 weeks

What else happened in CymaBay Therapeutics around then

Filed or reported within 30 days of the trade day · 23/09/09~23/11/08

Sujal Shah's recent trades

Sujal ShahCEO
Sell10b5-1 planCymaBay Therapeutics
Sell10b5-1 plan
CymaBay Therapeutics
CBAY
$1.3M
63,975 sh
$1.3M
Filed 23/12/11
Traded 23/12/11
Sujal ShahCEO
Sell10b5-1 planCymaBay Therapeutics
Sell10b5-1 plan
CymaBay Therapeutics
CBAY
$18.5K
890 sh
$18.5K
Filed 23/12/11
Traded 23/12/11
Sujal ShahCEO
Sell10b5-1 planCymaBay Therapeutics
Sell10b5-1 plan
CymaBay Therapeutics
CBAY
$699.3K
44,008 sh
$699.3K
Filed 23/11/14
Traded 23/11/13
Sujal ShahCEO
Sell10b5-1 planCymaBay Therapeutics
Sell10b5-1 plan
CymaBay Therapeutics
CBAY
$331.4K
20,855 sh
$331.4K
Filed 23/11/14
Traded 23/11/13